報價延遲最少15分鐘:2025/06/01 13:07 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
77.46 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.15/3.76
|
|
企業價值
8.24B
|
| 資產負債 |
|
每股賬面淨值
6.44
|
| 現金流量 |
|
現金流量率
0.02
|
| 損益表 |
|
收益
482.38M
|
|
每股收益
4.24
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/01 13:07 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH. |